PT  - JOURNAL ARTICLE
AU  - Pang, Genevieve C.
AU  - Hou, Amy T.
AU  - Bayudan, Krizhna L.
AU  - Frank, Ethan A.
AU  - Pastiglione, Jennifer
AU  - Pang, Lorrin W.
TI  - Pre-procedural testing improves estimated COVID-19 prevalence and trends
AID  - 10.1101/2022.04.13.22273200
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.13.22273200
4099  - http://medrxiv.org/content/early/2022/04/18/2022.04.13.22273200.short
4100  - http://medrxiv.org/content/early/2022/04/18/2022.04.13.22273200.full
AB  - Background COVID-19 positivity rates reported to the public may provide a distorted view of community trends because they tend to be inflated by high-risk groups, such as symptomatic patients and individuals with known exposures to COVID-19. This positive bias within high-risk groups has also varied over time, depending on testing capability and indications for being tested. In contrast, throughout the pandemic, routine COVID-19 screening tests for elective procedures and operations unrelated to COVID-19 risk have been administered by medical facilities to reduce transmission to medical staffing and other patients. We propose the use of these pre-procedural COVID-19 patient datasets to reduce biases in community trends and better understand local prevalence.Methods Using patient data from the Maui Medical Group clinic, we analyzed 12,640 COVID-19 test results from May 1, 2020 to March 16, 2021, divided into two time periods corresponding with Maui’s outbreak.Results Mean positivity rates were 0.1% for the pre-procedural group, 3.9% for the symptomatic group, 4.2% for the exposed group, and 2.0% for the total study population. Post-outbreak, the mean positivity rate of the pre-procedural group was significantly lower than the aggregate group (all other clinic groups combined). The positivity rates of both pre-procedural and aggregate groups increased over the study period, although the pre-procedural group showed a smaller rise in rate.Conclusions Pre-procedural groups may produce different trends compared to high-risk groups and are sufficiently robust to detect small changes in positivity rates. Considered in conjunction with high-risk groups, pre-procedural marker groups used to monitor understudied, low-risk subsets of a community may improve our understanding of community COVID-19 prevalence and trends.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was not supported by any funding sources.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Hawaii Department of Health's Institutional Review Board granted ethical approval for this study. This study was approved and qualified as exempt research under 45 CFR 46.116(d) of the Department of Health and Human Services, waiving informed consent based on the minimal risk associated with the de-identified patient data used in this study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.